Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 16, 2016 - Issue 3
Submit an article Journal homepage
493
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells

Lunchang WangCardiac Surgery, University of Michigan, Ann Arbor, MI, USA;Vascular Surgery, The Second Xiangya Hospital, Xiangya School of Medicine, Central South University, Hunan, China
,
Jiang HuBiologic and Materials Sciences, University of Michigan, Ann Arbor, MI, USA
,
Claire E SorekCardiac Surgery, University of Michigan, Ann Arbor, MI, USA
,
Eugene Y ChenCardiac Surgery, University of Michigan, Ann Arbor, MI, USA
,
Peter X MaBiologic and Materials Sciences, University of Michigan, Ann Arbor, MI, USA;Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA;Macromolecular Science and Engineering Center, University of Michigan, Ann Arbor, MI, USA;Materials Science and Engineering, University of Michigan, Ann Arbor, MI, USA
&
Bo YangCardiac Surgery, University of Michigan, Ann Arbor, MI, USACorrespondence[email protected]
Pages 317-330 | Received 10 Aug 2015, Accepted 16 Oct 2015, Published online: 08 Dec 2015

Bibliography

  • Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131(4):e29–e322.
  • Laslett LJ, Alagona P Jr, Clark BA 3rd, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol. 2012 Dec 25;60(25 Suppl):S1–49.
  • Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res. 2006;98(1):25–35.
  • L’Heureux N, Dusserre N, Marini A, et al. Technology insight: the evolution of tissue-engineered vascular grafts–from research to clinical practice. Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):389–395.
  • Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3(1):104–114.
  • Chard RB, Johnson DC, Nunn GR, et al. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. J Thorac Cardiovasc Surg. 1987 Jul;94(1):132–134.
  • Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg. 2001 Mar;33(3):533–539.
  • Kidane A, Lantz GC, Jo S, et al. Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies. J Biomater Sci Polym Ed. 1999;10(10):1089–1105.
  • Shinoka T, Breuer C. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med. 2008 Dec;81(4):161–166.
  • Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231(4736):397–400.
  • Swartz DD, Russell JA, Andreadis ST. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1451–60.
  • Cummings CL, Gawlitta D, Nerem RM, et al. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials. 2004 Aug;25(17):3699–3706.
  • Grassl ED, Oegema TR, Tranquillo RT. A fibrin-based arterial media equivalent. J Biomed Mater Res A. 2003;66(3):550–561.
  • Hoerstrup SP, Zund G, Sodian R, et al. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg. 2001 Jul;20(1):164–169.
  • Shum-Tim D, Stock U, Hrkach J, et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999;68(6):2298–2304.
  • Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science. 1999 Apr 16;284(5413):489–493.

• The first evidence of functional artery engineered in vitro.

  • Shinoka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiov Sur. 1998;115(3):536–545.
  • Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med. 2001 Feb 15;344(7):532–533.

•• Pioneering clinical trial with tissue-engineered vascular grafts fabricated from autologus bone marrow mononuclear cells for repair of congenital heart defect.

  • Shin’oka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 2005 Jun;129(6):1330–1338.

•• Midterm follow-up study of first clinical trial with tissue-engineered vascular grafts fabricated from autologus bone marrow mononuclear cells for repair of congenital heart defect.

  • L’Heureux N, McAllister TN, De La Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med. 2007;357(14):1451–1453.
  • Olausson M, Patil PB, Kuna VK, et al. Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet. 2012 Jul 21;380(9838):230–237.
  • Wystrychowski W, McAllister TN, Zagalski K, et al. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J Vasc Surg. 2014 Nov;60(5):1353–1357.
  • Li S, Sengupta D, Chien S. Vascular tissue engineering: from in vitro to in situ. Wiley Interdiscip Rev Syst Biol Med. 2014 Jan-Feb;6(1):61–76.
  • Bajpai VK, Andreadis ST. Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev. 2012 Oct;18(5):405–425.
  • Swartz DD, Andreadis ST. Animal models for vascular tissue-engineering. Curr Opin Biotech. 2013 Oct;24(5):916–925.
  • Syedain ZH, Meier LA, Bjork JW, et al. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials. 2011 Jan;32(3):714–722.
  • Syedain ZH, Meier LA, Lahti MT, et al. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng Pt A. 2014 Jun;20(11–12):1726–1734.
  • Shaikh FM, Callanan A, Kavanagh EG, et al. Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells, Tissues, Organs. 2008;188(4):333–346.
  • Wu W, Allen RA, Wang YD. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med. 2012 Jul;18(7):1148-+.
  • Tara S, Kurobe H, Maxfield MW, et al. Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft. J Vasc Surg. 2014;62(3):734–743.
  • Kurobe H, Maxfield MW, Tara S, et al. Development of small diameter nanofiber tissue engineered arterial grafts. Plos One. 2015;10(4):e0120328.
  • Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials. 2007 Dec;28(34):5009–5027.
  • Berger K, Wood SJ, Sauvage LR, et al. Healing of arterial prostheses in man - its incompleteness. Ann Surg. 1972;175(1):118.
  • Krawiec JT, Vorp DA. Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials. 2012 Apr;33(12):3388–3400.
  • Hu J, Sun X, Ma H, et al. Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials. 2010 Nov;31(31):7971–7977.
  • Xu ZC, Zhang WJ, Li H, et al. Engineering of an elastic large muscular vessel wall with pulsatile stimulation in bioreactor. Biomaterials. 2008;29(10):1464–1472.
  • Niklason LE, Abbott W, Gao J, et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg. 2001;33(3):628–638.
  • Xie C, Hu J, Ma H, et al. Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials. 2011;32(19):4369–4375.

• Pioneering and fundamental works on applying pluripotent stem cells in fabrication of tissue-engineered vascular tissues.

  • Hu J, Xie C, Ma H, et al. Construction of vascular tissues with macro-porous nano-fibrous scaffolds and smooth muscle cells enriched from differentiated embryonic stem cells. Plos One. 2012;7(4):e35580.

• Pioneering and fundamental works on applying pluripotent stem cells in fabrication of tissue-engineered vascular tissues.

  • Wang Y, Hu J, Jiao J, et al. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds. Biomaterials. 2014 Oct;35(32):8960–8969.

• Pioneering and fundamental works on applying pluripotent stem cells in fabrication of tissue-engineered vascular tissues.

  • Korbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept?. N Engl J Med. 2003;349(6):570–582.
  • Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180–192.
  • Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000;97(7):3213–3218.
  • De Ugarte DA, Alfonso Z, Zuk PA, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003;89(2–3):267–270.
  • Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009 Jan;217(2):318–324.
  • Matsumura G, Miyagawa-Tomita S, Shin’oka T, et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation. 2003;108(14):1729–1734.
  • Hibino N, McGillicuddy E, Matsumura G, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg. 2010;139(2):431–6, 36 e1–2.
  • Patterson JT, Gilliland T, Maxfield MW, et al. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. Regen Med. 2012;7(3):409–419.
  • Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4669–4674.

•• Study demonstrates limited vascular differentiation of bone marrow mononuclear cells (BM-MSCs) during vascular remodeling of tissue-engineered vascular grafts (TEVGs) in small animals and raises the debate on the role of BM-MSCs in fabricating TEVGs.

  • Ziegelhoeffer T, Heil M, Voswinckel R, et al. Bone marrow derived stem cells do not differentiate into vascular cells during collateral artery growth in mice. Circulation. 2002;106(19):82–82.
  • Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrow-derived cells do not incorporate in the adult growing vasculature. Circulation. 2003 Oct 28;108(17):222–223.
  • Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297(5590):2256–2259.
  • Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002 Apr 4;416(6880):542–545.
  • Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003 Oct 30;425(6961):968–973.
  • Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10(5):494–501.
  • Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg. 2005;241(3):506–515.
  • Cho SW, Lim JE, Chu HS, et al. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A. 2006;76(2):252–263.
  • Brennan MP, Dardik A, Hibino N, et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008;248(3):370–376.
  • Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2;284(5411):143–147.
  • Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004 Apr;36(4):568–584.
  • Liu JY, Peng HF, Gopinath S, et al. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng Pt A. 2010 Aug;16(8):2553–2564.
  • Hilfiker A, Kasper C, Hass R, et al. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?. Langenbeck Arch Surg. 2011 Apr;396(4):489–497.
  • Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007 Nov;213(2):341–347.
  • Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Statement. Cytotherapy. 2006;8(4):315–317.
  • Bieback K, Kern S, Kocaomer A, et al. Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng. 2008;18(1 Suppl):S71–6.
  • Hashi CK, Zhu Y, Yang GY, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11915–11920.

• Study demonstrates limited vascular differentiation of bone marrow mononuclear cells during vascular remodeling of tissue-engineered vascular grafts in small animals.

  • Zhang L, Zhou J, Lu Q, et al. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds. Biotechnol Bioeng. 2008;99(4):1007–1015.
  • Liu JY, Swartz DD, Peng HF, et al. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res. 2007;75(3):618–628.
  • Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008 Jun;22(6):1635–1648.
  • Zhao YL, Zhang S, Zhou JY, et al. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells. Biomaterials. 2010;31(2):296–307.
  • Wang S, Mundada L, Johnson S, et al. Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells. Stem Cells Transl Med. 2015;4(4):339–350.
  • Lin ZB, Qian B, Yang YZ, et al. Isolation, characterization and cardiac differentiation of human thymus tissue derived mesenchymal stromal cells. J Cell Biochem. 2014;116(7):1205–1212.
  • Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, et al. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells, Tissues, Organs. 2008;187(4):263–274.
  • Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A. 2006;103(32):12167–12172.
  • Harris LJ, Abdollahi H, Zhang P, et al. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J Surg Res. 2011;168(2):306–314.
  • Wang C, Cen L, Yin S, et al. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials. 2010;31(4):621–630.
  • Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004 Feb 10;109(5):656–663.
  • Cao Y, Sun Z, Liao LM, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Bioph Res Co. 2005;332(2):370–379.
  • Fischer LJ, McIlhenny S, Tulenko T, et al. Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res. 2009;152(1):157–166.
  • Zhang P, Moudgill N, Hager E, et al. Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev. 2011;20(6):977–988.
  • Wang C, Yin S, Cen L, et al. Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta 1 and bone morphogenetic protein-4. Tissue Eng Pt A. 2010;16(4):1201–1213.
  • Johal KS, Lees VC, Reid AJ. Adipose-derived stem cells: selecting for translational success. Regen Med. 2015 Jan;10(1):79–96.
  • Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 2006 Feb;15(1):49–60.
  • Liu JY, Peng HF, Andreadis ST. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res. 2008;79(1):24–33.
  • Liu X, Song L, Liu J, et al. miR-18b inhibits TGF-beta1-induced differentiation of hair follicle stem cells into smooth muscle cells by targeting SMAD2. Biochem Biophys Res Commun. 2013 Aug 30;438(3):551–556.
  • Weber B, Kehl D, Bleul U, et al. In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2013. DOI:10.1002/term.1781. [Epub ahead of print].
  • Hibino N, Nalbandian A, Devine L, et al. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng Part C Methods. 2011;17(10):993–998.
  • Kurobe H, Tara S, Maxfield MW, et al. Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts. Tissue Eng Part C Methods. 2014;21(6):597–604.
  • Beltrami AP, Cesselli D, Beltrami CA. At the stem of youth and health. Pharmacol Ther. 2011 Jan;129(1):3–20.
  • Madonna R, Renna FV, Cellini C, et al. Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. Eur J Clin Invest. 2011;41(2):126–133.
  • Han J, Liu JY, Swartz DD, et al. Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells. Cardiovasc Res. 2010;87(1):147–155.
  • Krawiec JT, Weinbaum JS, St Croix CM, et al. A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. Tissue Eng Pt A. 2015 Feb 1;21(3–4):426–437.
  • Bara JJ, Richards RG, Alini M, et al. Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells. 2014 Jul;32(7):1713–1723.
  • Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7634–7638.
  • Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998 Nov 6;282(5391):1145–1147.
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676.
  • Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30;131(5):861–872.
  • Okita K, Nakagawa M, Hong HJ, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949–953.
  • Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313–317.
  • Grskovic M, Javaherian A, Strulovici B, et al. Induced pluripotent stem cells–opportunities for disease modelling and drug discovery. Nat Rev Drug Discov. 2011 Dec;10(12):915–929.
  • Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature. 2012;481(7381):295–305.
  • Merkle FT, Eggan K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell. 2013;12(6):656–668.
  • Su RJ, Baylink DJ, Neises A, et al. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. Plos One. 2013;8(5):e64496.
  • Cao N, Liang H, Huang J, et al. Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 2013;23(9):1119–1132.
  • Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscl Throm Vas. 2007 Jun;27(6):1248–1258.
  • Cheung C, Bernardo AS, Trotter MW, et al. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol. 2012 Feb;30(2):165–173.
  • Chen YE. Vascular cell lineage determination and differentiation. Arterioscl Throm Vas. 2011 Jul;31(7):1467–1468.
  • Xie C, Ritchie RP, Huang H, et al. Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1485–1494.
  • Mack CP. Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscl Throm Vas. 2011 Jul;31(7):1495–1505.
  • Hibino N, Duncan DR, Nalbandian A, et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiov Sur. 2012;143(3):696–703.
  • Hu J, Wang Y, Jiao J, et al. Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration. Biomaterials. 2015 Sep 11;73:51–59.
  • Margariti A, Winkler B, Karamariti E, et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13793–13798.

• Partially induced pluripotent stem cell-derived smooth muscle cells and endothelial cells shortens fabrication time needed for tissue-engineered vascular grafts construction.

  • Karamariti E, Margariti A, Winkler B, et al. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through dkk3 signaling are potent for tissue engineering of vascular grafts. Circ Res. 2013 May 24;112(11):1433-+.

• Partially induced pluripotent stem cell-derived smooth muscle cells and endothelial cells shortens fabrication time needed for tissue-engineered vascular grafts construction.

  • Sundaram S, Echter A, Sivarapatna A, et al. Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells. Tissue Eng Pt A. 2014;20(3–4):740–750.
  • Sundaram S, One J, Siewert J, et al. Tissue-engineered vascular grafts created from human induced pluripotent stem cells. Stem Cell Transl Med. 2014;3(12):1535–1543.
  • Laurent LC, Ulitsky I, Slavin I, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011 Jan 7;8(1):106–118.
  • Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011 Mar 3;471(7336):63–67.
  • Yusa K, Rad R, Takeda J, et al. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods. 2009 May;6(5):363–369.
  • Zhou HY, Wu SL, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009 May 8;4(5):381–384.
  • Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013 Aug 9;341(6146):651–654.
  • Schlaeger TM, Daheron L, Brickler TR, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2015;33(1):58–63.
  • Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010 Oct 8;7(4):521–531.
  • Narva E, Autio R, Rahkonen N, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol. 2010;28(4):371–377.
  • Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011 Mar 3;471(7336):58–62.
  • MacCarrick G, Black JH 3rd, Bowdin S, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576–587.
  • Van Laer L, Dietz H, Loeys B. Loeys-Dietz syndrome. Adv Exp Med Biol. 2014;802:95–105.
  • Tang Z, Wang A, Yuan F, et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun. 2012;3:875.
  • Nguyen AT, Gomez D, Bell RD, et al. Smooth muscle cell plasticity: fact or fiction?. Circ Res. 2013 Jan 4;112(1):17–22.
  • Xu J, Du Y, Deng H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell. 2015;16(2):119–134.
  • Dahl SL, Kypson AP, Lawson JH, et al. Readily available tissue-engineered vascular grafts. Sci Transl Med. 2011 Feb 2;3(68):68ra9.
  • Quint C, Kondo Y, Manson RJ, et al. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A. 2011;108(22):9214–9219.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.